Cost Effectiveness of Therapies for Atrial Fibrillation: A Review

Author： Teng M.P.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.4, 2000-10, pp. : 317-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ximelagatran Cost Effectiveness for Stroke Prevention in Atrial Fibrillation

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 279-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation

By Verhoef Talitha I   Redekop William K   Veenstra David L   Thariani Rahber   Beltman Peter A   van Schie Rianne MF   de Boer Anthonius   Maitland-van der Zee Anke-Hilse  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 869-883

Future Medicine

Access to resources Recommend Favorite

Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation

By Craig I. Coleman   James S. Kalus   C. Michael White   Anne P. Spencer  

PharmacoEconomics, Vol. 22, Iss. 13, 2004-01 ,pp. : 877-883

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US

By Sullivan Patrick W.  

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 1021-1033

Adis International

Access to resources Recommend Favorite

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

By Benedict Ágnes   Brown Ruth E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1789-1801

Informa Healthcare

Access to resources Recommend Favorite